Decibel Therapeutics Inc. (DBTX)
NASDAQ: DBTX
· Real-Time Price · USD
4.91
-0.04 (-0.81%)
At close: Sep 22, 2023, 10:00 PM
Decibel Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -63.39M | -62.29M | -63.01M | -59.97M | -60.36M | -54.97M | -51.82M | -51.8M | -42.52M | -38.67M |
Depreciation & Amortization | 1.4M | 1.44M | 1.46M | 1.4M | 1.38M | 1.35M | 1.41M | 1.45M | 1.5M | 1.58M |
Stock-Based Compensation | 3.86M | 3.33M | 3.2M | 2.93M | 3.09M | 3.01M | 2.82M | 4.67M | 3.82M | 3.23M |
Other Working Capital | -5.05M | -2.98M | -4.78M | 4.59M | 11.31M | 11.24M | 11.78M | 7.56M | 1.46M | -354K |
Other Non-Cash Items | 1.28M | 1.49M | 1.77M | 1.83M | 1.7M | 1.28M | 952K | 652K | 370K | 99K |
Deferred Income Tax | -355K | n/a | 297K | 297K | 297K | 297K | n/a | n/a | n/a | n/a |
Change in Working Capital | 8.4M | 4.09M | -618K | -5.17M | -2.71M | 171K | 3.49M | 6.28M | 2.04M | -3.31M |
Operating Cash Flow | -48.81M | -51.95M | -56.9M | -58.68M | -56.61M | -48.85M | -43.15M | -38.75M | -34.79M | -37.06M |
Capital Expenditures | -496K | -628K | -463K | -591K | -864K | -781K | -745K | -532K | -224K | -282K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -71.42M | -61.18M | -97.51M | -103.59M | -89.48M | -120.55M | -197.46M | -192.3M | -173.81M | -142.74M |
Sales Maturities Of Investments | 103.66M | 140.84M | 153.07M | 147.97M | 165.46M | 129.03M | 97.07M | 70.67M | 26.53M | 5.78M |
Other Investing Acitivies | n/a | n/a | n/a | 97K | 97K | 139K | 139K | 42K | 134K | 92K |
Investing Cash Flow | 31.74M | 79.03M | 55.1M | 43.88M | 75.2M | 7.83M | -101M | -122.13M | -147.37M | -137.15M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12K | -15K | -15K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 294K | 36K | -213K | -7K | 98K | -690K | 152.51M | 206.75M | 207.16M | 208M |
Financial Cash Flow | 294K | 36K | -213K | -7K | 98K | -690K | 152.51M | 206.75M | 207.16M | 208M |
Net Cash Flow | -16.77M | 27.12M | -2.01M | -14.8M | 18.69M | -41.71M | 8.37M | 45.87M | 25.01M | 33.79M |
Free Cash Flow | -49.3M | -52.58M | -57.36M | -59.27M | -57.47M | -49.63M | -43.9M | -39.29M | -35.01M | -37.34M |